10-K: Aeluma Secures $12.6M, Boosts Revenue 408% in Strong FY25
Annual Report
Aeluma, Inc. reported a significant 408% increase in revenue for fiscal year 2025, driven by government contracts, and successfully raised $12.6 million in net proceeds from a public offering, alleviating prior going concern doubts.
Summary
- Aeluma, Inc. reported a substantial increase in revenue by 407.9% to $4.7 million for the fiscal year ended June 30, 2025, up from $919 thousand in the prior year.
- The company's net loss decreased by 33.8% to $3.0 million in fiscal year 2025, compared to $4.6 million in fiscal year 2024.
- Cash, cash equivalents, and certificates of deposit significantly increased to $15.7 million as of June 30, 2025, from $1.3 million as of June 30, 2024.
- Net proceeds from a public offering in March 2025 amounted to $12.6 million, which has alleviated substantial doubt about the company's ability to continue as a going concern for at least the next twelve months.
- Aeluma secured multiple government contracts, including an $11.7 million DARPA contract for nano-scale semiconductors and contracts with NASA, the U.S. Department of Energy, and the U.S. Navy.
- Convertible promissory notes totaling $3.1 million were converted into 898,573 shares of common stock at $3.50 per share in March 2025.
- The company filed a shelf registration statement on Form S-3 in July 2025, allowing for future sales of up to $100 million in securities.
- Christopher Stewart was appointed as the full-time Chief Financial Officer and Principal Accounting Officer in August 2025, replacing interim CFO James Seo.
- A material weakness in internal control over financial reporting was identified as of June 30, 2025, due to insufficient personnel with technical accounting and SEC reporting expertise.
Sentiment
Score: 8
Explanation: The company demonstrated exceptional revenue growth, significantly reduced its net loss, and secured substantial capital through a public offering, alleviating going concern doubts. Strong government contract wins validate its technology and market potential. While still an early-stage company with inherent risks and identified internal control weaknesses, the overall trajectory and financial strengthening are highly positive.
Positives
- Revenue increased by 407.9% to $4.7 million in FY2025, demonstrating strong growth, primarily driven by government contracts.
- Net loss improved by 33.8%, reducing to $3.0 million in FY2025 from $4.6 million in FY2024.
- Cash and cash equivalents, including a certificate of deposit, surged to $15.7 million as of June 30, 2025, from $1.3 million in the prior year, significantly bolstering liquidity.
- The successful public offering generated $12.6 million in net proceeds, which has alleviated previously reported substantial doubt about the company's ability to continue as a going concern for at least the next twelve months.
- Secured significant government contracts, including an $11.7 million DARPA contract and awards from NASA, the U.S. Department of Energy, and the U.S. Navy, validating technology and providing revenue streams.
- The conversion of $3.1 million in convertible notes into equity at a ceiling price of $3.50 per share eliminated debt obligations and strengthened the balance sheet.
- The company's technology, based on heterogeneous integration of compound semiconductors on large-diameter substrates, offers potential for 10x lower manufacturing costs for mass-market applications compared to traditional InGaAs sensors.
- Aeluma maintains approximately 30 issued and pending patents, along with trade secrets, providing strong intellectual property protection.
- The appointment of Christopher Stewart as a full-time CFO is expected to help resolve identified material weaknesses in internal controls and enhance financial reporting expertise.
Negatives
- The company remains in early development stages and is not yet in volume production for any of its product offerings, leading to continuing net losses and negative cash flows from operations.
- A material weakness in internal control over financial reporting was identified as of June 30, 2025, due to an insufficient number of personnel with appropriate technical accounting and SEC reporting expertise.
- The company is dependent on a limited number of customers, particularly government agencies, with 71% of FY2025 revenue derived from a single customer (Customer E), posing a concentration risk.
- There is no assurance that current customer engagements for engineering samples and small-volume orders will translate into large-volume purchases.
- The semiconductor industry is highly competitive, with larger, more established competitors possessing greater financial resources and market recognition.
- The company relies on third-party suppliers and contract manufacturers for wafer fabrication, packaging, and testing, exposing it to risks of manufacturing delays, pricing fluctuations, and quality control issues.
- The company does not currently maintain product liability insurance, which could expose it to substantial liabilities if products fail or cause injury once commercial operations commence.
- The company's operations are concentrated in Goleta, California, making it susceptible to disruptions from natural disasters like earthquakes.
- The company does not currently intend to pay dividends on its common stock in the foreseeable future, meaning investor returns depend solely on stock price appreciation.
Risks
- The company is in early development stages with a limited operating history, making it difficult to evaluate business and prospects, and faces continuing net losses and negative cash flows.
- Failure to raise additional capital or generate sufficient cash flows could limit the ability to expand operations and compete successfully, despite the recent public offering and shelf registration.
- Inability to successfully implement the growth strategy on a timely basis, including expanding partnerships, acquiring new customers, scaling technology, and ensuring a consistent supply chain.
- Longer-than-anticipated timelines for the adoption of technologies by customers, which could delay revenue growth.
- Potential impacts from changes to regulatory agencies, such as the Presidents Department of Government Efficiency (DOGE), which could lead to funding reductions, delays in approvals, or contract terminations.
- Government contracts, which form a substantial portion of revenue, are subject to high competition, changing certification requirements, budgetary cycles, and termination for convenience.
- Dependence on the management team and key employees, with the loss of whom or inability to attract qualified personnel (especially due to high local housing costs) could harm the business.
- Material weaknesses in internal control over financial reporting could result in material misstatements in financial statements and negatively affect market price and trading liquidity.
- Failure to protect and enforce intellectual property rights and confidential information could weaken the competitive position and lead to costly litigation.
- The highly cyclical nature of the semiconductor industry, with significant downturns or upturns in customer demand, can materially adversely affect business and results of operations.
- Rapid innovation and short product life cycles in the semiconductor industry can lead to price erosion of older products and require substantial, continuous R&D investments.
- Shortages or increased prices of raw materials, including rare earths or minerals like indium, gallium, and arsenic, could materially adversely affect results of operations.
- Geopolitical conflicts and changes in import tariffs could impact the availability and cost of raw materials and equipment, affecting profitability and strategic growth.
- Disruptions or breaches of information technology systems or security could irreparably damage reputation, expose to liability, and adversely affect results of operations, especially given limited current investments in data security.
- The common stock may be subject to penny stock regulations and restrictions, making it difficult for investors to sell shares and potentially limiting market liquidity.
Future Outlook
Aeluma plans to continue developing its core intellectual property, focusing on manufacturing high-performance semiconductor technologies that scale for mass markets across various verticals including mobile, automotive, AI, defense & aerospace, communication, AR/VR, HPC, and quantum computing. The company intends to mature its manufacturing processes, expand business development and marketing efforts, and engage further with manufacturing partners to achieve volume production and commercialization. With the recent capital raise, existing cash and projected revenues are believed to be sufficient to meet working capital and capital expenditure requirements for at least the next twelve months, though additional financing opportunities may be pursued for long-term growth.
Management Comments
- Management has assessed our financial position and operating plan and determined that the previously reported substantial doubt about our ability to continue as a going concern has been alleviated.
- The proceeds from the Offering have provided near-term capital to support our operations and ongoing development efforts.
Industry Context
Aeluma operates in the rapidly evolving and highly competitive semiconductor industry, targeting high-growth markets such as CMOS image sensors (projected $28.6 billion by 2029), automotive lidar ($5 billion to $80 billion by 2030), AI ($826 billion by 2030), silicon photonics ($8 billion by 2030), and quantum computing ($20 billion by 2030). The global semiconductor market is projected to exceed $1 trillion by 2030. Aeluma's focus on heterogeneous integration of compound semiconductors on large-diameter substrates positions it to address the increasing demand for high-performance, cost-effective solutions in these mass markets, aiming to disrupt traditional manufacturing methods.
Comparison to Industry Standards
- Aeluma aims to compete with major suppliers of silicon CMOS image sensors such as Sony, Samsung, Omnivision, onsemi, STMicroelectronics, Panasonic, Canon, and SK Hynix, by offering superior performance.
- The company also targets the high-performance compound semiconductor market, competing with InGaAs sensor suppliers like Hamamatsu, Sumitomo, Teledyne/FLIR, and Excelitas.
- Aeluma's technology leverages larger diameter substrates (up to 12-inch) compared to the typical 2to 4-inch substrates used for InGaAs sensors, enabling the potential for 10 times lower manufacturing costs and much larger area photodetector arrays for mass market applications.
- Aeluma's photodetectors offer higher detection sensitivity and a broader wavelength absorption spectrum, extending into the shortwave infrared (SWIR) spectrum (900-1700 nm), which is considered eye-safe, unlike the near-infrared cutoff of silicon sensors (near 940 nm).
- While Apple currently uses VCSEL emitters with single-photon avalanche diode (SPAD) photodetectors for facial identification and lidar in its mobile devices, Aeluma's technology is broadly applicable to mobile and consumer electronics, indicating potential for future market penetration.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer/Principal Accounting Officer | James Seo (Interim) | Christopher Stewart | 2025-08-04 | Appointment of a full-time CFO to enhance financial leadership and address internal control weaknesses. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | The Board of Directors consists of five members, divided into three classes with staggered three-year terms. Four directors (Mr. DenBaars, Mr. Paglia, Mr. Ensley, and Mr. Byron) are considered independent. | As of September 9, 2025 | Provides a structured governance framework with a majority of independent directors, enhancing oversight and accountability, though the staggered board may inhibit rapid change of control. |
| Committee Structure | Established three standing committees: Audit (chaired by John Paglia, an audit committee financial expert), Compensation (chaired by Craig Ensley), and Nominating and Governance (chaired by Steven P. DenBaars). All committee members meet independence standards. | As of September 9, 2025 | Ensures specialized oversight in critical areas like financial reporting, executive compensation, and board nominations, aligning with best practices for public companies. |
| Code of Business Conduct and Ethics | Adopted a Code of Ethics applicable to all directors and employees, providing fundamental ethical principles. | Prior to September 25, 2023 | Establishes clear ethical guidelines for company personnel, promoting integrity and compliance with regulatory standards. |
| Board Leadership Structure | Mr. Jonathan Klamkin serves as both Chief Executive Officer and Chairman of the Board, a combined role. | Ongoing | Aims to ensure common purpose between board and management and a clear chain of command, but could potentially reduce independent oversight compared to a split role. |
Legal Proceedings
- No material litigation, arbitration, governmental proceeding, or any other legal proceeding is currently pending or known to be contemplated against the company or its management team.
Related Party Transactions
- The company has an Advisory Agreement with Mr. Steven DenBaars, a director, under which he was granted the right to purchase 241,903 shares of common stock (vested as of the report date) as partial compensation for advisory services.
Stakeholder Impact
- **Shareholders**: Experienced significant dilution from the public offering and convertible note conversions, but the capital raise alleviated going concern doubts and improved liquidity, potentially supporting future growth and stock appreciation. Future equity offerings under the S-3 shelf registration could lead to further dilution.
- **Employees**: The company plans to hire additional personnel and may offer stock options for attraction and retention. Stock-based compensation is a significant component of executive and director compensation.
- **Customers**: The company is actively engaging with approximately 20 prospective customers and has secured multiple government contracts, indicating growing demand for its technology. However, customers may require lengthy qualification processes without sales assurance.
- **Suppliers**: The company relies on third-party fabrication foundries and packaging companies, and disruptions or increased costs from these suppliers could impact operations and product delivery.
- **Creditors**: The conversion of $3.1 million in convertible notes into equity eliminated debt obligations, improving the company's financial health and reducing credit risk.
Next Steps
- Continue to develop technology, including novel materials and devices, based on core intellectual property.
- Mature manufacturing processes to further commercialization traction.
- Expand business development and marketing efforts.
- Further engage with manufacturing partners to scale production capacity for high-volume markets.
- Continue efforts toward volume production and commercialization.
- Address and remediate the identified material weakness in internal control over financial reporting.
- Evaluate the accounting impact of the new Goleta office lease under ASC 842, Leases.
Key Dates
| Date | Description |
|---|---|
| 2020-08-21 | Aeluma, Inc. (then Parc Investments, Inc.) was incorporated in Delaware. |
| 2021-04-01 | Commencement of a 5-year operating lease for a facility in Santa Barbara, California. |
| 2021-06-05 | Steven P. DenBaars joined Biond Photonics (now Aeluma) Board of Directors. |
| 2021-06-22 | Company name changed to Aeluma, Inc. from Parc Investments, Inc. |
| 2022-08-26 | Common stock began trading on the OTCQB system under the symbol ALMU. |
| 2023-09-10 | The company repurchased 649,570 unvested restricted shares from former interim CFO Lee McCarthy. |
| 2024-08 | Received a contract from NASA to develop quantum dot photonic integrated circuits (PICs) on silicon. |
| 2024-08-05 | Beginning of the period during which convertible promissory notes in the aggregate principal amount of $3.1 million were issued to 10 accredited investors. |
| 2024-08-27 | End of the period during which convertible promissory notes in the aggregate principal amount of $3.1 million were issued to 10 accredited investors. |
| 2024-09 | Received an $11.7 million contract with DARPA to develop heterogeneous integration technology. |
| 2025-01-27 | The Board of Directors approved an increase in Mr. Klamkin's annual salary to $295,000. |
| 2025-03-18 | Mr. James Seo agreed to serve as Aeluma's interim Chief Financial Officer/Principal Accounting Officer. |
| 2025-03-25 | A Conversion Event occurred for the convertible notes, leading to the issuance of 898,573 shares of Common Stock at $3.50 per share. |
| 2025-03-26 | Entered into an Underwriting Agreement for a public offering of 2,285,714 shares of common stock at $5.25 per share. Common stock began trading on the Nasdaq Capital Market. |
| 2025-03-27 | The Underwriter's 30-day option to purchase an additional 342,857 shares was exercised in full. |
| 2025-03-28 | The public offering closed, generating $12.6 million in net proceeds. |
| 2025-04 | Received a contract with the U.S. Department of Energy to develop commercially viable, low-cost shortwave infrared (SWIR) photodetectors. |
| 2025-05-14 | CEO Mr. Jonathan Klamkin adopted a Rule 10b5-1 trading arrangement (later terminated). |
| 2025-06 | Received two contracts with the U.S. Navy for high-speed photodetectors and next-generation quantum computing/sensing systems. |
| 2025-06-06 | Entered into a lease agreement for additional corporate office space in Goleta, California. |
| 2025-06-23 | Director Mr. Steven DenBaars adopted a Rule 10b5-1 trading arrangement. |
| 2025-07-31 | Filed a registration statement on Form S-3 with the SEC, using a shelf registration process for up to $100,000,000 in securities. |
| 2025-08-04 | Mr. Christopher Stewart agreed to serve as Aeluma's Chief Financial Officer/Principal Accounting Officer, replacing Mr. James Seo. |
| 2025-08-08 | The shelf registration statement (File No. 3330289135) was declared effective. |
| 2025-08-14 | 150,000 shares were sold under Mr. Klamkin's trading plan. |
| 2025-08-18 | Mr. Klamkin terminated his trading plan. |
| 2025-09-05 | Conditions for the new Goleta office lease were met, making it non-cancellable, with a 5-year term commencing in September 2025. |
| 2025-09-07 | As of this date, there were 15,892,887 shares of common stock outstanding and 41 stockholders of record. |
| 2025-09-09 | Date of the Annual Report on Form 10-K filing. |
Recommendation
buyAeluma's fiscal year 2025 results demonstrate significant progress for an early-stage semiconductor company. The 408% revenue growth, substantial reduction in net loss, and a strong increase in cash and working capital are compelling indicators of positive momentum. The successful $12.6 million public offering and the alleviation of going concern doubts address critical financial risks. Furthermore, securing multiple government contracts, including a major DARPA award, validates the company's innovative technology and its broad market applicability in high-growth sectors like AI, defense, and quantum computing. While risks associated with being an early-stage company, reliance on third-party manufacturing, and internal control weaknesses exist, the strong execution in securing funding, driving revenue, and advancing technology positions Aeluma for significant future upside. The potential for 10x lower manufacturing costs compared to competitors also presents a strong competitive advantage. For a seasoned investor, these developments suggest a strong 'buy' opportunity, anticipating continued growth and market penetration.
Keywords
Semiconductor, Photodetectors, Quantum Computing, AI, Defense & Aerospace, 5G/6G, SWIR, Heterogeneous Integration, Compound Semiconductor, Nasdaq, SEC Filing, Annual Report, Goleta, California, Optoelectronics, Wafer-scale platform
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.